PUMA BIOTECHNOLOGY, INC. Long-Term Debt, Maturity, Year One
PUMA BIOTECHNOLOGY, INC. (PBYI) had Long-Term Debt, Maturity, Year One of $11.34 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-05-07
- 2026-03-31: Long-Term Debt, Maturity, Year One $11.34M.
- 2025-12-31: Long-Term Debt, Maturity, Year One $22.68M.
- 2025-09-30: Long-Term Debt, Maturity, Year One $22.68M.
- 2025-06-30: Long-Term Debt, Maturity, Year One $22.68M.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2026-03-31 | $11.34M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $22.68M 10-K · filed 2026-02-26 |
| 2025-09-30 | $22.68M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $22.68M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $22.67M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $45.33M 10-K · filed 2025-02-27 |
| 2024-09-30 | $45.33M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $45.33M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $45.33M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $34.00M 10-K · filed 2024-02-29 |
| 2023-09-30 | $34.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $34.00M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |